SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

IRLAB Receives U.S. Notice of Allowance for IRL1117 Patent

IRLAB Therapeutics received a U.S. notice of allowance for its IRL1117 patent.

Related stories